<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36217108</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1528-3658</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Molecular medicine (Cambridge, Mass.)</Title><ISOAbbreviation>Mol Med</ISOAbbreviation></Journal><ArticleTitle>Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism.</ArticleTitle><Pagination><StartPage>122</StartPage><MedlinePgn>122</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">122</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-022-00548-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long-COVID is characterized by prolonged, diffuse symptoms months after acute COVID-19. Accurate diagnosis and targeted therapies for Long-COVID are lacking. We investigated vascular transformation biomarkers in Long-COVID patients.</AbstractText><AbstractText Label="METHODS">A case-control study utilizing Long-COVID patients, one to six months&#xa0;(median 98.5 days) post-infection, with multiplex immunoassay measurement of sixteen blood biomarkers of vascular transformation, including ANG-1, P-SEL, MMP-1, VE-Cad, Syn-1, Endoglin, PECAM-1, VEGF-A, ICAM-1, VLA-4, E-SEL, thrombomodulin, VEGF-R2, VEGF-R3, VCAM-1 and VEGF-D.</AbstractText><AbstractText Label="RESULTS">Fourteen vasculature transformation blood biomarkers were significantly elevated in Long-COVID outpatients, versus acutely ill COVID-19 inpatients and healthy controls subjects (P&#x2009;&lt;&#x2009;0.05). A unique two biomarker profile consisting of ANG-1/P-SEL was developed with machine learning, providing a classification accuracy for Long-COVID status of 96%. Individually, ANG-1 and P-SEL had excellent sensitivity and specificity for Long-COVID status (AUC&#x2009;=&#x2009;1.00, P&#x2009;&lt;&#x2009;0.0001; validated in a secondary cohort). Specific to Long-COVID, ANG-1 levels were associated with female sex and a lack of disease interventions at follow-up (P&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS">Long-COVID patients suffer prolonged, diffuse symptoms and poorer health. Vascular transformation blood biomarkers were significantly elevated in Long-COVID, with angiogenesis markers (ANG-1/P-SEL) providing classification accuracy of 96%. Vascular transformation blood biomarkers hold potential for diagnostics, and modulators of angiogenesis may have therapeutic efficacy.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Maitray A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-1141-8253</Identifier><AffiliationInfo><Affiliation>Epidemiology and Biostatistics, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knauer</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-2240-4730</Identifier><AffiliationInfo><Affiliation>Pathology and Laboratory Medicine, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medicine, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daley</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6939-9772</Identifier><AffiliationInfo><Affiliation>Epidemiology and Biostatistics, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computer Science, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Nynatten</LastName><ForeName>Logan R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Medicine, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3971-3166</Identifier><AffiliationInfo><Affiliation>Medicine, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Eric K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0003-3697-3042</Identifier><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cepinskas</LastName><ForeName>Gediminas</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0267-6659</Identifier><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Biophysics, Western University, London, ON, N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seney</LastName><ForeName>Shannon L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobretzberger</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Thermo Fisher Scientific, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miholits</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Thermo Fisher Scientific, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Thermo Fisher Scientific, Rockford, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Douglas D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0002-5635-3791</Identifier><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics, Western University, London, ON, N6A 3K7, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurological Sciences, Western University, London, ON, N6A 3K7, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiology and Pharmacology, Western University, London, ON, N6A 3K7, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>London Health Sciences Centre, Room C2-C82, 800 Commissioners Road East, London, ON, N6A 5W9, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Med</MedlineTA><NlmUniqueID>9501023</NlmUniqueID><ISSNLinking>1076-1551</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071063">Endoglin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039041">Integrin alpha4beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019408">Platelet Endothelial Cell Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018180">Thrombomodulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019010">Vascular Cell Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042643">Vascular Endothelial Growth Factor D</NameOfSubstance></Chemical><Chemical><RegistryNumber>126547-89-5</RegistryNumber><NameOfSubstance UI="D018799">Intercellular Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.7</RegistryNumber><NameOfSubstance UI="D020781">Matrix Metalloproteinase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071063" MajorTopicYN="N">Endoglin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039041" MajorTopicYN="N">Integrin alpha4beta1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018799" MajorTopicYN="N">Intercellular Adhesion Molecule-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020781" MajorTopicYN="N">Matrix Metalloproteinase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019408" MajorTopicYN="N">Platelet Endothelial Cell Adhesion Molecule-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018180" MajorTopicYN="N">Thrombomodulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019010" MajorTopicYN="N">Vascular Cell Adhesion Molecule-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042643" MajorTopicYN="N">Vascular Endothelial Growth Factor D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiogenesis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Vascular transformation</Keyword></KeywordList><CoiStatement>V.D., M.M. and B.W. are employees of Thermo Fisher Scientific Inc. who manufacture and distribute multiplex immunoassays as research use only reagents. The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36217108</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pii">10.1186/s10020-022-00548-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsimas D, et al. COVID-19 mortality risk assessment: an international multi-center study. PLoS ONE. 2020;15:e0243262. doi: 10.1371/journal.pone.0243262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243262</ArticleId><ArticleId IdType="pmc">PMC7725386</ArticleId><ArticleId IdType="pubmed">33296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju PK, et al. COVID-19 in critically ill patients in the seattle region&#x2014;case series. N Engl J Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7143164</ArticleId><ArticleId IdType="pubmed">32227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley AP. The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recogn. 1997;30:1145&#x2013;1159. doi: 10.1016/S0031-3203(96)00142-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-3203(96)00142-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindle NPJ, Saharinen P, Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 2006;98:1014&#x2013;1023. doi: 10.1161/01.RES.0000218275.54089.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000218275.54089.12</ArticleId><ArticleId IdType="pmc">PMC2270395</ArticleId><ArticleId IdType="pubmed">16645151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisson AR, Matsui D, Rieder MJ, Fraser DD. Translational research in pediatrics: tissue sampling and biobanking. Pediatrics. 2012;129:153&#x2013;162. doi: 10.1542/peds.2011-0134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-0134</ArticleId><ArticleId IdType="pubmed">22144705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cani E, et al. Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality. Crit Care Explor. 2021;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8718216</ArticleId><ArticleId IdType="pubmed">34984340</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel [Internet]. Available from: https://www.fda.gov/media/134922/download.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673615</ArticleId><ArticleId IdType="pubmed">34910739</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis S, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 1996;87:1161&#x2013;1169. doi: 10.1016/S0092-8674(00)81812-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81812-7</ArticleId><ArticleId IdType="pubmed">8980223</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Diacovo TG, Puri KD, Warnock RA, Springer TA, Von Andrian UH. Platelet-mediated lymphocyte delivery to high endothelial venules. Science. 1996;273:252&#x2013;255. doi: 10.1126/science.273.5272.252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.273.5272.252</ArticleId><ArticleId IdType="pubmed">8662511</ArticleId></ArticleIdList></Reference><Reference><Citation>Egami K, Murohara T, Aoki M, Matsuishi T. Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin. J Leukoc Biol. 2006;79:971&#x2013;976. doi: 10.1189/jlb.0805448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0805448</ArticleId><ArticleId IdType="pubmed">16641139</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, et al. Inflammation profiling of critically ill coronavirus disease 2019 patients. Crit Care Explor. 2020;2:e0144. doi: 10.1097/CCE.0000000000000144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000144</ArticleId><ArticleId IdType="pmc">PMC7314329</ArticleId><ArticleId IdType="pubmed">32696007</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, et al. Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation. Crit Care Explor. 2020;2:e0194. doi: 10.1097/CCE.0000000000000194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000194</ArticleId><ArticleId IdType="pmc">PMC7449254</ArticleId><ArticleId IdType="pubmed">32904031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, et al. Novel outcome biomarkers identified with targeted proteomic analyses of plasma from critically ill coronavirus disease 2019 patients. Crit Care Explor. 2020;2:e0189. doi: 10.1097/CCE.0000000000000189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000189</ArticleId><ArticleId IdType="pmc">PMC7449255</ArticleId><ArticleId IdType="pubmed">32904064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, et al. Metabolomics profiling of critically ill coronavirus disease 2019 patients: identification of diagnostic and prognostic biomarkers. Crit Care Explor. 2020;2:e0272. doi: 10.1097/CCE.0000000000000272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000272</ArticleId><ArticleId IdType="pmc">PMC7587450</ArticleId><ArticleId IdType="pubmed">33134953</ArticleId></ArticleIdList></Reference><Reference><Citation>Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med. 2004;10:171&#x2013;178. doi: 10.1016/j.molmed.2004.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2004.02.008</ArticleId><ArticleId IdType="pubmed">15059608</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin MR, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410499</ArticleId><ArticleId IdType="pubmed">32633718</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilaki E, Eftychidis I, Papassotiriou I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. J Lab Med. 2021;45:293&#x2013;302. doi: 10.1515/labmed-2021-0134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/labmed-2021-0134</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill SE, et al. Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation. Intensive Care Med Exp. 2020;8:75. doi: 10.1186/s40635-020-00361-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-020-00361-9</ArticleId><ArticleId IdType="pmc">PMC7729690</ArticleId><ArticleId IdType="pubmed">33306162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillio-Meina C, Cepinskas G, Cecchini EL, Fraser DD. Translational research in pediatrics II: blood collection, processing, shipping, and storage. Pediatrics. 2013;131:754&#x2013;766. doi: 10.1542/peds.2012-1181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-1181</ArticleId><ArticleId IdType="pubmed">23509173</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582. doi: 10.1016/S2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41:1100&#x2013;1115. doi: 10.1016/j.it.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH HRPP. (2009) Policy: guidelines for limits of blood drawn for research purposes in the clinical Center. M95&#x2013;9 (rev.) June 5.</Citation></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jambu M. Chapter 10&#x2014;classification of Individuals-Variables Data Sets. In: Jambu M, editor. Exploratory and multivariate data analysis. Boston: Academic Press; 1991. pp. 305&#x2013;405.</Citation></Reference><Reference><Citation>Juneja GK, et al. Biomarkers of coagulation, endothelial function and fibrinolysis in critically-ill patients with COVID-19: a single-centre prospective longitudinal study. J Thromb Haemost. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250276</ArticleId><ArticleId IdType="pubmed">33826233</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama S, Ishii KJ, Coban C, Akira S. Innate immune response to viral infection. Cytokine. 2008;43:336&#x2013;341. doi: 10.1016/j.cyto.2008.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2008.07.009</ArticleId><ArticleId IdType="pubmed">18694646</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;mpers P, et al. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis. 2009;68:1638. doi: 10.1136/ard.2008.094664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2008.094664</ArticleId><ArticleId IdType="pubmed">18930996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kursa MB, Rudnicki WR. Feature selection with the Boruta package. J Stat Softw. 2010;36:1&#x2013;13. doi: 10.18637/jss.v036.i11.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i11</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorant DE, et al. Inflammatory roles of P-selectin. J Clin Investig. 1993;92:559&#x2013;570. doi: 10.1172/JCI116623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116623</ArticleId><ArticleId IdType="pmc">PMC294887</ArticleId><ArticleId IdType="pubmed">7688760</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Maaten L, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008; 9.</Citation></Reference><Reference><Citation>Matta J, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbidelli L, Brogelli L, Granger HJ, Ziche M. Endothelial cell migration is induced by soluble P-selectin. Life Sci. 1998;62:P17&#x2013;P11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9444972</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323:2195. doi: 10.1001/jama.2020.7202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.7202</ArticleId><ArticleId IdType="pmc">PMC7182961</ArticleId><ArticleId IdType="pubmed">32329797</ArticleId></ArticleIdList></Reference><Reference><Citation>Priestap F, Kao R, Martin CM. External validation of a prognostic model for intensive care unit mortality: a retrospective study using the Ontario Critical Care Information System. Can J Anaesth. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223438</ArticleId><ArticleId IdType="pubmed">32383124</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, et al. Cytokine signatures in chronic fatigue syndrome patients: a case control study and the effect of anakinra treatment. J Transl Med. 2017;15:267. doi: 10.1186/s12967-017-1371-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1371-9</ArticleId><ArticleId IdType="pmc">PMC5747240</ArticleId><ArticleId IdType="pubmed">29284500</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, et al. Pitfalls in cytokine measurements&#x2014;plasma TGF-&#x3b2;1 in chronic fatigue syndrome. Neth J Med. 2018;76:310&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">30220655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack KD, Kellum JA, Parikh SM. The angiopoietin-Tie2 pathway in critical illness. Crit Care Clin. 2020;36:201&#x2013;216. doi: 10.1016/j.ccc.2019.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2019.12.003</ArticleId><ArticleId IdType="pmc">PMC8843037</ArticleId><ArticleId IdType="pubmed">32172809</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne) 2020;7:594495. doi: 10.3389/fmed.2020.594495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.594495</ArticleId><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Senna MK, Machaly SA, Foda M, Eid N. Baseline angiopoietin-2/angiopoietin-1 (Ang2/Ang1) ratio is correlated with the synovial vascularity measured 1 month later in rheumatoid arthritis. Egypt Rheumatol Rehabil. 2013;40:193&#x2013;197. doi: 10.4103/1110-161X.123797.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1110-161X.123797</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Garreau D, von Luxburg U. When do random forests fail? In: NeurIPS. 2018; pp. 2987&#x2013;2997.</Citation></Reference><Reference><Citation>Thurston G. Complementary actions of VEGF and Angiopoietin-1 on blood vessel growth and leakage*. J Anat. 2002;200:575&#x2013;580. doi: 10.1046/j.1469-7580.2002.00061.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1469-7580.2002.00061.x</ArticleId><ArticleId IdType="pmc">PMC1570748</ArticleId><ArticleId IdType="pubmed">12162725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tvaro&#x161;ka I, Selvaraj C, Ko&#x10d;a J. Selectins&#x2014;the two Dr. Jekyll and Mr. Hyde faces of adhesion molecules&#x2014;a review. Molecules. 2020;25:2835. doi: 10.3390/molecules25122835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25122835</ArticleId><ArticleId IdType="pmc">PMC7355470</ArticleId><ArticleId IdType="pubmed">32575485</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Brumfield SA, Lara Mejia PS. Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a critical review of research methods. Front Neurol 2019; 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454267</ArticleId><ArticleId IdType="pubmed">31001197</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, et al. ICU admission levels of endothelial biomarkers as predictors of mortality in critically ill COVID-19 patients. Cells. 2021;10:186. doi: 10.3390/cells10010186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010186</ArticleId><ArticleId IdType="pmc">PMC7832393</ArticleId><ArticleId IdType="pubmed">33477776</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter C, et al. Erythrocyte, platelet, serum ferritin, and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int J Mol Sci. 2020;21:8234. doi: 10.3390/ijms21218234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatim N, et al. Platelet activation in critically ill COVID-19 patients. Annal Intensive Care 2021; 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286043</ArticleId><ArticleId IdType="pubmed">34273008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:108427. doi: 10.1016/j.clim.2020.108427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108427</ArticleId><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>